Voice Rest and Injection Laryngoplasty
Launched by UNIVERSITY OF VIRGINIA · Sep 12, 2022
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how resting your voice after receiving an injection to help with vocal cord paralysis affects your voice quality and breathing. The study aims to find out if taking a break from speaking can improve outcomes compared to patients who continue to use their voice as normal after the procedure.
To participate, you need to be over 18 years old and plan to have an injection to enhance your vocal cords for reasons like weakness or immobility. However, if you’ve had recent radiation treatment for head and neck issues, are undergoing chemotherapy, or have certain other medical conditions, you won’t be eligible to join. If you take part in the trial, you’ll be monitored to see how well your voice improves with or without voice rest after the procedure. This could help doctors understand the best ways to support patients with vocal cord problems in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age \>18 years old
- 2. Undergoing injection augmentation by Dr. McGarey, Dr. Torrecillas, or Dr. Daniero for the following conditions:
- • 1. Glottic insufficiency from atrophy, scar, or presbylarynx
- • 2. Unilateral or bilateral vocal fold immobility
- • 3. Unilateral or bilateral vocal fold hypomobility
- Exclusion Criteria:
- • 1. Prior history of head and neck radiation.
- • 2. Active or recent (within 3 months) chemotherapy.
- • 3. Age \<18 years old
- • 4. Incarcerated individuals will be excluded due to inability to enroll in post-intervention clinic visit
- • 5. Presence of posterior glottic stenosis
- • 6. Presence of acute laryngeal injury
- • 7. Bedside inpatient injection augmentation
- • 8. Vocal fold Injection with steroids or cidofovir
About University Of Virginia
The University of Virginia (UVA) is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, UVA leverages its extensive resources and expertise in various fields, including medicine, engineering, and public health, to drive cutting-edge studies that address pressing health challenges. The university's clinical trial programs aim to translate scientific discoveries into effective treatments, ensuring the highest standards of ethical practice and participant safety. Through its strong emphasis on community engagement and education, UVA fosters a culture of research that not only contributes to the scientific community but also enhances the well-being of the populations it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charlottesville, Virginia, United States
Patients applied
Trial Officials
James J Daniero, MD
Principal Investigator
University of Virginia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials